1. Home
  2. FLXS vs SLN Comparison

FLXS vs SLN Comparison

Compare FLXS & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLXS
  • SLN
  • Stock Information
  • Founded
  • FLXS 2001
  • SLN 1994
  • Country
  • FLXS United States
  • SLN United Kingdom
  • Employees
  • FLXS N/A
  • SLN N/A
  • Industry
  • FLXS Home Furnishings
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLXS Consumer Discretionary
  • SLN Health Care
  • Exchange
  • FLXS Nasdaq
  • SLN Nasdaq
  • Market Cap
  • FLXS 175.4M
  • SLN 165.3M
  • IPO Year
  • FLXS N/A
  • SLN N/A
  • Fundamental
  • Price
  • FLXS $36.51
  • SLN $5.80
  • Analyst Decision
  • FLXS
  • SLN Buy
  • Analyst Count
  • FLXS 0
  • SLN 5
  • Target Price
  • FLXS N/A
  • SLN $32.60
  • AVG Volume (30 Days)
  • FLXS 19.5K
  • SLN 123.0K
  • Earning Date
  • FLXS 08-18-2025
  • SLN 08-14-2025
  • Dividend Yield
  • FLXS 1.81%
  • SLN N/A
  • EPS Growth
  • FLXS N/A
  • SLN N/A
  • EPS
  • FLXS 2.55
  • SLN N/A
  • Revenue
  • FLXS $437,284,000.00
  • SLN $27,701,000.00
  • Revenue This Year
  • FLXS $8.34
  • SLN N/A
  • Revenue Next Year
  • FLXS $4.01
  • SLN N/A
  • P/E Ratio
  • FLXS $14.74
  • SLN N/A
  • Revenue Growth
  • FLXS 7.24
  • SLN N/A
  • 52 Week Low
  • FLXS $28.81
  • SLN $1.97
  • 52 Week High
  • FLXS $65.87
  • SLN $22.47
  • Technical
  • Relative Strength Index (RSI)
  • FLXS 62.25
  • SLN 59.55
  • Support Level
  • FLXS $33.99
  • SLN $5.06
  • Resistance Level
  • FLXS $37.71
  • SLN $6.25
  • Average True Range (ATR)
  • FLXS 1.89
  • SLN 0.49
  • MACD
  • FLXS 0.74
  • SLN -0.01
  • Stochastic Oscillator
  • FLXS 85.58
  • SLN 64.00

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: